OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies Guest UserMay 5, 2021
PCI Biotech: First US patient enrolled in the fimaCHEM pivotal RELEASE study Guest UserApril 30, 2021
PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation Guest UserFebruary 10, 2021
PCI Biotech: Successful Phase I fimaVACC vaccination proof of concept study to be published in Frontiers in Immunology Guest UserNovember 23, 2020
PCI Biotech: European patent for treatment of bile duct cancer with the fimaCHEM technology Guest UserNovember 16, 2020
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital Guest UserSeptember 3, 2020
PCI Biotech announce a research collaboration with DCprime to explore novel cancer vaccination concepts Guest UserSeptember 1, 2020
